Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: From bench to bedside
David W. Dodick
Neurology
Research output
:
Contribution to journal
›
Article
›
peer-review
55
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: From bench to bedside'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Primary Headache Disorders
100%
Type A Botulinum Toxins
84%
Neurotoxins
79%
Migraine Disorders
70%
Biological Toxins
17%
Blepharospasm
14%
Hemifacial Spasm
14%
Blepharoptosis
14%
Placebos
13%
Torticollis
13%
Diplopia
11%
Neuromuscular Junction
11%
Pain
11%
Injections
11%
Therapeutics
11%
Muscle Contraction
10%
Acetylcholine
9%
Smooth Muscle
8%
Neurotransmitter Agents
8%
Analgesics
8%
Randomized Controlled Trials
6%